FDA Must Clarify Ephedra Case Impact – Supplement Trade Groups

FDA needs to "act promptly to address issues raised" by the recent Utah federal court decision that challenged aspects of the agency's ban on ephedra, leading supplement trade groups state in a joint letter to the agency